Positive results of preclinical studies confirm the potential of Neurizon’s lead drug candidate NUZ-001 to be a ...
In this GEN webinar, experts from WuXi AppTec will share essential strategies and methodologies for accelerating pre-clinical ...
Managing director and CEO Dr Michael Thurn said the results were important in the development of NUZ-001. “The positive results from these preclinical studies are a significant milestone ...
Schrödinger has already generated several computational predictive models of off-target drug activity. The company’s recent advances characterizing the structure of safety-related proteins such as ...
Positive results of preclinical studies confirm the potential of Neurizon’s lead drug candidate NUZ-001 ... neurons and in turn contributes to the development of ALS symptoms.
Drug development is the synthesis of large ... available data and the significant upfront investment to generate the preclinical experimental data to adequately train a model, the question ...
The business combination of two AI-powered drug discovery and development companies, Recursion (Nasdaq: RXRX) and Exscientia ...
Absci Corporation has secured key partnerships but lacks advanced assets. Find out why ABSI stock is still a speculative ...
CN Bio, a leading provider of Organ-on-a-chip Systems and solutions that accelerate drug discovery and development workflows, today announced the launch of its PhysioMimix® Bioavailability assay kit: ...
The Newcells aProximateTM near-physiological kidney transporter model provides cross-species comparison of drug handling.